Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity
Clinical trial NCT03759782 · UNKNOWN
Trial details
- NCT number
- NCT03759782
- Sponsor
- Ottawa Hospital Research Institute
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-10
- Primary completion
- 2022-01-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.